Literature DB >> 10090347

V2-receptor-mediated relaxation of human renal arteries in response to desmopressin.

P Medina1, G Segarra, J M Vila, P Chuan, C Domenech, S Lluch.   

Abstract

The effects of deamino-8-D-arginine vasopressin (desmopressin), a V2 receptor antidiuretic agonist, were studied in isolated rings from branches of renal arteries obtained from 22 patients undergoing nephrectomy. The rings were suspended in organ bath chambers for isometric recording of tension. In precontracted rings with norepinephrine (10(-6) to 3 x 10(-6) mol/L), desmopressin (10(-11) to 3 x 10(-7) mol/L) caused endothelium-dependent relaxation (81%+/-4% reversal of the initial contraction in arteries with endothelium; 20%+/-4% in arteries without endothelium; P < .05). The relaxation to desmopressin in rings with endothelium was reduced significantly by indomethacin (10(-6) mol/L) and unaffected by the inhibitor of nitric oxide synthase NG-nitro-L-arginine methyl ester (10(-4) mol/L). Two V1 receptor antagonists (a peptidic and a nonpeptidic) had no effect on desmopressin-induced relaxation. However, V2 receptor antagonists (three peptidic and a nonpeptidic) reduced significantly (P < .05) the maximal response to desmopressin. The results of this study show that desmopressin exerts powerful endothelium-dependent relaxation of human renal arteries, probably through stimulation of V2-like receptors that may bring about the release of dilating prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090347     DOI: 10.1016/s0895-7061(98)00230-1

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

Review 1.  Desmopressin: in adults with nocturia.

Authors:  Risto S Cvetković; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  A comparison between haemodynamic effects of vasopressin analogues.

Authors:  Reza Tabrizchi; Carol Ann Ford
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-27       Impact factor: 3.000

3.  Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment.

Authors:  Youko Ikeda; Irina Zabbarova; Mathijs de Rijk; Anthony Kanai; Amanda Wolf-Johnston; Jeffrey P Weiss; Edwin Jackson; Lori Birder
Journal:  Continence (Amst)       Date:  2022-05-25

4.  Age dependency of vasopressin pulmonary vasodilatory effect in rats.

Authors:  Masahiro Enomoto; Jingyi Pan; Yulia Shifrin; Jaques Belik
Journal:  Pediatr Res       Date:  2013-11-20       Impact factor: 3.756

5.  Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report.

Authors:  Kento Ikegawa; Rumi Hachiya; Kazuhisa Akiba; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2022-02-18

6.  Diabetes diminishes the portal-systemic collateral vascular response to vasopressin via vasopressin receptor and Gα proteins regulations in cirrhotic rats.

Authors:  Jing-Yi Lee; Teh-Ia Huo; Sun-Sang Wang; Hui-Chun Huang; Fa-Yauh Lee; Han-Chieh Lin; Chiao-Lin Chuang; Shou-Dong Lee
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.